The University of Chicago Header Logo


Peter Riedell to Cell- and Tissue-Based Therapy

This is a "connection" page, showing publications Peter Riedell has written about Cell- and Tissue-Based Therapy.
Connection Strength

  1. Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. Leuk Lymphoma. 2021 06; 62(6):1497-1501.
    View in: PubMed
    Score: 0.201
  2. Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome. Blood Adv. 2023 09 12; 7(17):4765-4772.
    View in: PubMed
    Score: 0.060
  3. Biomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients. Eur Heart J. 2023 Jun 09; 44(22):2029-2042.
    View in: PubMed
    Score: 0.059
  4. Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood. 2021 06 17; 137(24):3454-3459.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.